claRx Dermatology Blog

A patient waiting a week for a medication change is unacceptable. We can make a positive impact here. 

Provider protocols are not new to the world of medicine. Physicians have been using them for years in hospitals in order to allow a more team centered approach between providers and pharmacists. This team approach gives patients better care and lower costs.

Simply defined, iPledge is a patient safety program for patients on or intending to take isotretinoin and it is designed to prevent harm from coming to unborn children of pregnant women, as well as other potential harmful side effects if not monitored by your provider. In technical terms, it is a REMS (Risk Evaluation and Mitigation Strategy) program implemented through the FDA.

The rising cost of mediations in dermatology has not stopped to be a source of worry over the years. It can be described as a disastrous development, and it does not look to stop anytime soon. The costs have increased dramatically in multiple folds over the years, which honestly is an outrageous situation. As a result of this, patients that are suffering from significant skin disorders that can be easily treated often go without therapy just for financial reasons. This also affects the pharmacists and dermatologists that are taking care of these patients.